Speqta - A Post-COVID-19 Winner
Redeye reiterates its positive view on Speqta as the company reported sequential growth despite COVID-19 challenges, and we maintain a positive outlook. The company´s sales came in stronger than expected, and the company seems to handle the second wave of the pandemic well. Looking beyond the pandemic, we believe that Speqta is a winner as we expect to see a strong recovery, especially for Rahalaitos. Hence, we maintain our positive stance on Speqta and continue to see a significant upside in the stock.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/